We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
AnTolRx, Inc., a private biotechnology company and a leader in immune tolerance, today announced that Pfizer Inc has exercised the option granted under a June 2016 agreement to license an immune...